10 November 2017Americas

LSIPR 50 2017: Tim Haines

Name: Tim Haines

Organisation: Abingworth

Position: Managing partner

With more than 25 years of international management experience in the life sciences industry in both public and private companies, Tim Haines, managing partner of international investment group Abingworth, takes a spot in LSIPR 50.

Haines joined Abingworth in 2005, an investment company which has raised $375 million since 2010. The company was founded in 1973 and is dedicated exclusively to the life sciences and healthcare sectors.

One of the company’s more notable investments was in CRISPR Therapeutics, an early-stage biopharmaceutical company created to translate CRISPR-Cas9, the breakthrough gene-editing technology, into medicines. The company formed a collaboration with Vertex Pharmaceuticals, in a deal worth up to $2.6 billion

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk